The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">Test</td><td class="align_center">HPE malignant</td><td class="align_center">HPE benign</td><td class="align_center">Total</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">FNA Bethesda categories IV, V, VI</td><td class="align_center">21</td><td class="align_center">4</td><td class="align_center">25</td></tr><tr><td class="align_left">FNA Bethesda categories II, III</td><td class="align_center">8</td><td class="align_center">66</td><td class="align_center">74</td></tr><tr><td class="align_left">Total</td><td class="align_center">29</td><td class="align_center">70</td><td class="align_center">99</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Determination of diagnostic values.</div>

Journal of Thyroid Research

tab3

Table 3

Table 3: The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study 